Back to results
US 2022/0089714 A1Published application
Treatment Of Non-Alcoholic Steatohepatitis (NASH) With IL-27 Antibody
AssigneeInstitute for Cancer Research d/b/a The Research Institute of Fox Chase Cancer Center
InventorEkaterina Koltsova
Life of this patent
Estimating the term…
Abstract
The present disclosure provides methods of treating non-alcoholic steatohepatitis (NASH) in a subject by administering to the subject an inhibitor of IL-27 or IL-27R.
Claims7
A method of treating non-alcoholic steatohepatitis (NASH) in a subject, the method comprising administering to the subject an inhibitor of IL-27 or IL-27R.
Dependencies are inferred from the claim text.